全文获取类型
收费全文 | 435篇 |
免费 | 27篇 |
国内免费 | 2篇 |
专业分类
儿科学 | 5篇 |
基础医学 | 93篇 |
口腔科学 | 2篇 |
临床医学 | 37篇 |
内科学 | 35篇 |
皮肤病学 | 53篇 |
神经病学 | 67篇 |
特种医学 | 33篇 |
外科学 | 46篇 |
综合类 | 3篇 |
一般理论 | 1篇 |
预防医学 | 23篇 |
眼科学 | 1篇 |
药学 | 50篇 |
肿瘤学 | 15篇 |
出版年
2022年 | 4篇 |
2021年 | 5篇 |
2020年 | 9篇 |
2019年 | 6篇 |
2018年 | 10篇 |
2017年 | 8篇 |
2016年 | 12篇 |
2015年 | 13篇 |
2014年 | 28篇 |
2013年 | 15篇 |
2012年 | 35篇 |
2011年 | 12篇 |
2010年 | 14篇 |
2009年 | 13篇 |
2008年 | 20篇 |
2007年 | 24篇 |
2006年 | 20篇 |
2005年 | 36篇 |
2004年 | 17篇 |
2003年 | 13篇 |
2002年 | 20篇 |
2001年 | 25篇 |
2000年 | 16篇 |
1999年 | 7篇 |
1997年 | 5篇 |
1994年 | 4篇 |
1992年 | 3篇 |
1991年 | 4篇 |
1990年 | 2篇 |
1989年 | 2篇 |
1987年 | 2篇 |
1985年 | 2篇 |
1983年 | 3篇 |
1981年 | 2篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1975年 | 3篇 |
1974年 | 5篇 |
1973年 | 3篇 |
1972年 | 2篇 |
1971年 | 3篇 |
1970年 | 4篇 |
1969年 | 2篇 |
1968年 | 2篇 |
1967年 | 3篇 |
1966年 | 4篇 |
1965年 | 2篇 |
1952年 | 1篇 |
排序方式: 共有464条查询结果,搜索用时 15 毫秒
461.
Brunner J Stalla GK Stalla J Uhr M Grabner A Wetter TC Bronisch T 《Journal of psychiatric research》2001,35(1):1-9
Several lines of evidence suggest a dysregulation of the adrenocortical (HPA) system with hypersecretion of CRH is associated with suicidal behavior. However, controversial results have emerged from the determination of corticotropin-releasing hormone (CRH) concentrations in the lumbar cerebrospinal fluid (CSF) of suicide attempters probably due to methodological differences. We simultaneously measured CRH concentrations in the CSF and in the plasma of 41 psychiatric in-patients with different diagnoses (affective disorder, schizophrenia, personality disorders, adjustment disorder, substance abuse) and eight neurological control subjects. We also measured plasma cortisol concentrations because data from animal experiments suggest that cortisol may influence CSF CRH concentrations. The major finding was that patients who attempted suicide prior to admission had significantly lower CSF CRH concentrations than psychiatric patients without suicidal behavior. CRH concentrations were significantly higher in the CSF than in plasma in both, psychiatric patients and neurological control subjects. There was no significant difference between suicide attempters and patients with acute suicidal ideations. The latter group showed a trend towards lower CSF CRH concentrations compared with the neurological control subjects. Patients with affective disorder alone as well as patients with multiple diagnoses, but not schizophrenic patients, showed significantly lower CSF CRH concentrations than neurological control subjects. Plasma CRH and plasma cortisol concentrations did not differ among diagnostic groups or between suicide attempters vs. non-attempters. Further studies with more homogeneous samples, drug-free patients and with simultaneous assessment of various parameters of the HPA system are warranted. 相似文献
462.
Nakane M Cowart MD Hsieh GC Miller L Uchic ME Chang R Terranova MA Donnelly-Roberts DL Namovic MT Miller TR Wetter JM Marsh K Stewart AO Brioni JD Moreland RB 《Neuropharmacology》2005,49(1):112-121
2-[4-(3,4-Dimethylphenlyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393) was identified as a potent dopamine D4 receptor antagonist with excellent receptor selectivity. [3H]-spiperone competition binding assays showed that A-381393 potently bound to membrane from cells expressing recombinant human dopamine D4.4 receptor (Ki=1.5 nM), which was 20-fold higher than that of clozapine (Ki=30.4 nM). A-381393 exhibited highly selective binding for the dopamine D4.4 receptor (>2700-fold) when compared to D1, D2, D3 and D5 dopamine receptors. Furthermore, in comparison to clozapine and L-745870, A-381393 exhibits better receptor selectivity, showing no affinity up to 10 microM for a panel of more than 70 receptors and channels, with the exception of moderate affinity for 5-HT2A (Ki=370 nM). A-381393 potently inhibited the functional activity of agonist-induced GTP-gamma-S binding assay and 1 microM dopamine induced-Ca2+ flux in human dopamine D4.4 receptor expressing cells, but not in human dopamine D2L or D3 receptor cells. In contrast to L-745870, A-381393 did not exhibit any significant intrinsic activity in a D4.4 receptor. In vivo, A-381393 has good brain penetration after subcutaneous administration. A-381393 inhibited penile erection induced by the selective D4 agonist PD168077 in conscious rats. Thus, A-381393 is a novel selective D4 antagonist that will enhance the ability to study dopamine D4 receptors both in vitro and in vivo. 相似文献
463.
Prof. Dr. T.C. Wetter M.A. G. Klösch M.Sc. 《Somnologie - Schlafforschung und Schlafmedizin》2013,17(4):271-280
Neuroimaging techniques provide fundamental and new insights into the neurobiology of the restless legs syndrome (RLS). Consequently, SPECT, PET and MR imaging of elements of the dopaminergic and iron system may contribute to elucidate pathophysiological mechanisms underlying this frequent sleep-related movement disorder. However, SPECT and PET studies of the nigrostriatal pre- and postsynaptic dopamine receptor binding potentials have produced controversial results, possibly reflecting a subtle receptor dysfunction of the central dopaminergic system. In addition, alterations of the iron system as shown in MRI studies may produce a dopaminergic abnormality contributing to the RLS pathology. However, particularly due to methodological and technical limitations, no definite conclusions are possible and more refined functional and structural imaging studies are necessary. 相似文献
464.
Immunoglobulin A anti‐phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes,vascular events and damage accrual 下载免费PDF全文
M. Frodlund G. Grosso T. Skogh J. Wetterö K. Elvin I. Gunnarsson A. Kastbom Ö. Dahlström J. Rönnelid E. Svenungsson C. Sjöwall 《Clinical and experimental immunology》2018,194(1):27-38
Immunoglobulin (Ig) G‐ and IgM‐class anti‐cardiolipin antibodies (aCL) and lupus anti‐coagulant (LA) are included in the 1997 update of the American College of Rheumatology (ACR‐97) systemic lupus erythematosus (SLE) criteria. Despite limited evidence, IgA‐aCL and IgA anti‐β2‐glycoprotein‐I (anti‐β2GPI) were included in the 2012 Systemic Lupus International Collaborating Clinics criteria. The present study aimed to evaluate IgG‐/IgA‐/IgM‐aCL and anti‐β2GPI occurrence in relation to disease phenotype, smoking habits, pharmacotherapy, anti‐phospholipid syndrome (APS) and organ damage among 526 Swedish SLE patients meeting ACR‐97. Patients with rheumatoid arthritis (n = 100), primary Sjögren’s syndrome (n = 50) and blood donors (n = 507) served as controls. Anti‐phospholipid antibodies (aPL) were analysed by fluoroenzyme‐immunoassays detecting aCL/anti‐β2GPI. Seventy‐six (14%) SLE cases fulfilled the Sydney APS‐criteria, and ≥ 1 aCL/anti‐β2GPI isotype (IgG/IgA/IgM) occurred in 138 SLE patients (26%). Forty‐five (9%) of the SLE cases had IgA‐aCL, 20 of whom (4%) lacked IgG‐/IgM‐aCL. Seventy‐four (14%) tested positive for IgA anti‐β2GPI, 34 (6%) being seronegative regarding IgG/IgM anti‐β2GPI. Six (1%) had APS manifestations but were seropositive regarding IgA‐aCL and/or IgA anti‐β2GPI in the absence of IgG/IgM‐aPL and LA. Positive LA and IgG‐aPL tests were associated with most APS‐related events and organ damage. Exclusive IgA anti‐β2GPI occurrence associated inversely with Caucasian ethnicity [odds ratio (OR) = 0·21, 95% confidence interval (CI) = 0·06–0·72) and photosensitivity (OR = 0·19, 95% CI = 0·05–0·72). Nephritis, smoking, LA‐positivity and statin/corticosteroid‐medication associated strongly with organ damage, whereas hydroxychloroquine‐medication was protective. In conclusion, IgA‐aPL is not rare in SLE (16%) and IgA‐aPL analysis may have additional value among SLE cases with suspected APS testing negative for other isotypes of aPL and LA. 相似文献